26.02.2019
- The EU is adopting new rules that should make it easier for producers of generic drugs and biosimilars in member states to compete on the global market. On Feb. 20, the states...
15.11.2017
- US pharmaceutical giant Pfizer has divested its 49% stake in Hisun-Pfizer Pharmaceuticals its Chinese joint venture with Zhejiang Hisun Pharma. As part of the plan, Sapphire I...
15.11.2016
- The US Department of Justice (DOJ) is stepping up its broad criminal investigation into suspected price fixing for generic drugs. A Grand Jury probe in the two-year-old case is...
11.05.2016
- Israel-based Teva, the world's largest generic drugmaker, still expects its $40.5 billion acquisition of Allergan's generics business, which trades as Actavis, to close in June...
28.01.2016
- The pharmaceutical industry has often been accused of trying to keep affordable generic drugs off the market, with the addition – for example – of new indications or product...
26.10.2015
- California-based Imprimis Pharmaceuticals is touting a customizable compounded formulation of pyrimethamine and leucovorin as a low cost alternative to Daraprim, the drug that made...
07.10.2015
- The need to get products quicker to market, to ensure greater regulatory compliance and to boost efficiencies while reducing operational cost is a challenging goal. Owing to the...
07.10.2015
- International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people around the world. The core of the...
